CSL’s new brand positioning is actually its first—and it comes after more than 100 years in business. CSL, the parent of biotherapy maker CSL Behring and its flu vaccine division Seqirus, was originally founded as a government agency in Australia in 1916 to source therapies for the then-isolated island country. But CSL has since come a long way.Original Article
You may also like
New alloys for manufacturing freeze-dryers
Navigating the Complexities of Emerging Therapy...
INTERPHEX 2025: Preventing Spills in the Manufacturing...
Agentic AI Growth Predicted, but More Than Half of...
Microsoft and SkyCell Collaborate on Pharma Supply...
Siemens Acquires Dotmatics, Extending AI Software...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.